Lisa M. Arendt, Ph.D. - Publications

2007 University of Wisconsin, Madison, Madison, WI 
Cell Biology, Oncology

22 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any innacuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2016 Sokol ES, Miller DH, Breggia A, Spencer KC, Arendt LM, Gupta PB. Growth of human breast tissues from patient cells in 3D hydrogel scaffolds. Breast Cancer Research : Bcr. 18: 19. PMID 26926363 DOI: 10.1186/s13058-016-0677-5  0.36
2015 Schubert SM, Arendt LM, Zhou W, Baig S, Walter SR, Buchsbaum RJ, Kuperwasser C, Walt DR. Ultra-sensitive protein detection via Single Molecule Arrays towards early stage cancer monitoring. Scientific Reports. 5: 11034. PMID 26052106 DOI: 10.1038/srep11034  0.36
2015 Mazumdar S, Arendt LM, Phillips S, Sedic M, Kuperwasser C, Gill G. CoREST1 promotes tumor formation and tumor stroma interactions in a mouse model of breast cancer. Plos One. 10: e0121281. PMID 25793264 DOI: 10.1371/journal.pone.0121281  0.36
2014 McCready J, Arendt LM, Glover E, Iyer V, Briendel JL, Lyle SR, Naber SP, Jay DG, Kuperwasser C. Pregnancy-associated breast cancers are driven by differences in adipose stromal cells present during lactation. Breast Cancer Research : Bcr. 16: R2. PMID 24405573 DOI: 10.1186/bcr3594  0.36
2013 Arendt LM, McCready J, Keller PJ, Baker DD, Naber SP, Seewaldt V, Kuperwasser C. Obesity promotes breast cancer by CCL2-mediated macrophage recruitment and angiogenesis. Cancer Research. 73: 6080-93. PMID 23959857 DOI: 10.1158/0008-5472.CAN-13-0926  0.36
2012 Asher JM, O'Leary KA, Rugowski DE, Arendt LM, Schuler LA. Prolactin promotes mammary pathogenesis independently from cyclin D1. The American Journal of Pathology. 181: 294-302. PMID 22658484 DOI: 10.1016/j.ajpath.2012.03.041  0.36
2012 Iyer V, Klebba I, McCready J, Arendt LM, Betancur-Boissel M, Wu MF, Zhang X, Lewis MT, Kuperwasser C. Estrogen promotes ER-negative tumor growth and angiogenesis through mobilization of bone marrow-derived monocytes. Cancer Research. 72: 2705-13. PMID 22467173 DOI: 10.1158/0008-5472.CAN-11-3287  0.36
2012 Keller PJ, Arendt LM, Skibinski A, Logvinenko T, Klebba I, Dong S, Smith AE, Prat A, Perou CM, Gilmore H, Schnitt S, Naber SP, Garlick JA, Kuperwasser C. Defining the cellular precursors to human breast cancer. Proceedings of the National Academy of Sciences of the United States of America. 109: 2772-7. PMID 21940501 DOI: 10.1073/pnas.1017626108  0.36
2011 Keller PJ, Arendt LM, Kuperwasser C. Stem cell maintenance of the mammary gland: it takes two. Cell Stem Cell. 9: 496-7. PMID 22136921 DOI: 10.1016/j.stem.2011.11.008  0.36
2011 Rudnick JA, Arendt LM, Klebba I, Hinds JW, Iyer V, Gupta PB, Naber SP, Kuperwasser C. Functional heterogeneity of breast fibroblasts is defined by a prostaglandin secretory phenotype that promotes expansion of cancer-stem like cells. Plos One. 6: e24605. PMID 21957456 DOI: 10.1371/journal.pone.0024605  0.36
2011 Chaffer CL, Brueckmann I, Scheel C, Kaestli AJ, Wiggins PA, Rodrigues LO, Brooks M, Reinhardt F, Su Y, Polyak K, Arendt LM, Kuperwasser C, Bierie B, Weinberg RA. Normal and neoplastic nonstem cells can spontaneously convert to a stem-like state. Proceedings of the National Academy of Sciences of the United States of America. 108: 7950-5. PMID 21498687 DOI: 10.1073/pnas.1102454108  0.36
2011 Arendt LM, Rugowski DE, Grafwallner-Huseth TA, Garcia-Barchino MJ, Rui H, Schuler LA. Prolactin-induced mouse mammary carcinomas model estrogen resistant luminal breast cancer. Breast Cancer Research : Bcr. 13: R11. PMID 21276249 DOI: 10.1186/bcr2819  0.6
2010 Keller PJ, Lin AF, Arendt LM, Klebba I, Jones AD, Rudnick JA, DiMeo TA, Gilmore H, Jefferson DM, Graham RA, Naber SP, Schnitt S, Kuperwasser C. Mapping the cellular and molecular heterogeneity of normal and malignant breast tissues and cultured cell lines. Breast Cancer Research : Bcr. 12: R87. PMID 20964822 DOI: 10.1186/bcr2755  0.36
2010 McCready J, Arendt LM, Rudnick JA, Kuperwasser C. The contribution of dynamic stromal remodeling during mammary development to breast carcinogenesis. Breast Cancer Research : Bcr. 12: 205. PMID 20584344 DOI: 10.1186/bcr2578  0.36
2010 Arendt LM, Rudnick JA, Keller PJ, Kuperwasser C. Stroma in breast development and disease. Seminars in Cell & Developmental Biology. 21: 11-8. PMID 19857593 DOI: 10.1016/j.semcdb.2009.10.003  0.36
2009 Arendt LM, Evans LC, Rugowski DE, Garcia-Barchino MJ, Rui H, Schuler LA. Ovarian hormones are not required for PRL-induced mammary tumorigenesis, but estrogen enhances neoplastic processes. The Journal of Endocrinology. 203: 99-110. PMID 19635758 DOI: 10.1677/JOE-09-0221  0.36
2009 Carver KC, Arendt LM, Schuler LA. Complex prolactin crosstalk in breast cancer: new therapeutic implications. Molecular and Cellular Endocrinology. 307: 1-7. PMID 19524120 DOI: 10.1016/j.mce.2009.03.014  0.6
2009 Arendt LM, Grafwallner-Huseth TL, Schuler LA. Prolactin-growth factor crosstalk reduces mammary estrogen responsiveness despite elevated ERalpha expression. The American Journal of Pathology. 174: 1065-74. PMID 19179608 DOI: 10.2353/ajpath.2009.080719  0.6
2008 Arendt LM, Schuler LA. Transgenic models to study actions of prolactin in mammary neoplasia. Journal of Mammary Gland Biology and Neoplasia. 13: 29-40. PMID 18219562 DOI: 10.1007/s10911-008-9073-9  0.6
2008 Arendt LM, Schuler LA. Prolactin drives estrogen receptor-alpha-dependent ductal expansion and synergizes with transforming growth factor-alpha to induce mammary tumors in males. The American Journal of Pathology. 172: 194-202. PMID 18156207 DOI: 10.2353/ajpath.2008.070597  0.6
2006 Arendt LM, Rose-Hellekant TA, Sandgren EP, Schuler LA. Prolactin potentiates transforming growth factor alpha induction of mammary neoplasia in transgenic mice. The American Journal of Pathology. 168: 1365-74. PMID 16565509  0.6
2003 Rose-Hellekant TA, Arendt LM, Schroeder MD, Gilchrist K, Sandgren EP, Schuler LA. Prolactin induces ERalpha-positive and ERalpha-negative mammary cancer in transgenic mice. Oncogene. 22: 4664-74. PMID 12879011 DOI: 10.1038/sj.onc.1206619  0.6
Show low-probability matches.